Long-Term Complications of Kidney Transplantation
By:
and
Angelina R. Edwards Texas A&M University, School of Engineering Medicine, Houston, TX
Division of Renal Disease and Hypertension, Houston Methodist Hospital, Houston, Texas

Search for other papers by Angelina R. Edwards in
Current site
Google Scholar
PubMed Close
Hassan N. Ibrahim Division of Transplant Nephrology, University of Texas at Houston Health Science Center, Houston, Texas
Transplant Center, Memorial Hermann Hospital, Houston, Texas

Search for other papers by Hassan N. Ibrahim in
Current site
Google Scholar
PubMed Close
Volume/Issue:
Volume 21: Issue 3
Published Online:
Aug 2022
Restricted access
Purchase Print On-Demand ASN Members Sign In Here
  • Collapse
  • Expand

Volume 21: Issue 3 (Aug 2022): Transplantation

in Nephrology Self-Assessment Program
Cover Nephrology Self-Assessment Program
Copyright:
Copyright © 2022 by the American Society of Nephrology 2022
Page Count:
16
Article Category:
Research Article
Print Publication Date:
01 Aug 2022
Published Online:
Aug 2022
  • 1

    Agrawal A, Ison MG, Danziger-Isakov L: Long-term infectious complications of kidney transplantation. Clin J Am Soc Nephrol 17: 286–295, 2022 10.2215/CJN.15971020 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Cohen G: Immune dysfunction in uremia 2020. Toxins (Basel) 12: 439, 2020 10.3390/toxins12070439 PubMed

  • 3

    Espi M, Koppe L, Fouque D, Thaunat O: Chronic kidney disease-associated immune dysfunctions: Impact of protein-bound uremic retention solutes on immune cells. Toxins (Basel) 12: 300, 2020 10.3390/toxins12050300 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Luo D, Zhao W, Lin Z, Wu J, Lin H, Li Y, et al.: The effects of hemodialysis and peritoneal dialysis on the gut microbiota of end-stage renal disease patients, and the relationship between gut microbiota and patient prognoses. Front Cell Infect Microbiol 11: 579386, 2021 10.3389/fcimb.2021.579386 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    Salvadori M, Tsalouchos A: Microbiota, renal disease and renal transplantation. World J Transplant 11: 16–36, 2021 10.5500/wjt.v11.i3.16 PubMed

  • 6

    Kim JS, Sze C, Barbar T, Lee JR: New insights into the microbiome in kidney transplantation. Curr Opin Organ Transplant 26: 582–586, 2021 10.1097/MOT.0000000000000921 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Midturi JK, Ranganath S: Prevention and treatment of multidrug-resistant organisms in end-stage renal disease. Adv Chronic Kidney Dis 26: 51–60, 2019 10.1053/j.ackd.2018.09.003 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    Anesi JA, Blumberg EA, Han JH, Lee DH, Clauss H, Hasz R, et al.; CDC Prevention Epicenters Program: Impact of donor multidrug-resistant organisms on solid organ transplant recipient outcomes. Transpl Infect Dis 24: e13783, 2022 10.1111/tid.13783 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    So M, Hand J, Forrest G, Pouch SM, Te H, Ardura MI, et al.: White paper on antimicrobial stewardship in solid organ transplant recipients. Am J Transplant 22: 96–112, 2022 10.1111/ajt.16743 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Goldman JD, Julian K: Urinary tract infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33: e13507, 2019 10.1111/ctr.13507 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Coussement J, Kamar N, Matignon M, Weekers L, Scemla A, Giral M, et al.; Bacteriuria in Renal Transplantation (BiRT) study group: Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): A pragmatic, multicentre, randomized, controlled trial. Clin Microbiol Infect 27: 398–405, 2021 10.1016/j.cmi.2020.09.005 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Coussement J, Kaminski H, Scemla A, Manuel O: Asymptomatic bacteriuria and urinary tract infections in kidney transplant recipients. Curr Opin Infect Dis 33: 419–425, 2020 10.1097/QCO.0000000000000678 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Thompson ER, Hosgood SA, Nicholson ML, Wilson CH: Early versus late ureteric stent removal after kidney transplantation. Cochrane Database Syst Rev 1: CD011455, 2018 10.1002/14651858.CD011455.pub2 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Wang Y, Yang Y, Zhang H, Wang Y: Early removal of ureteral stent after kidney transplant could decrease incidence of urinary tract infection: A systematic review and meta-analysis. Exp Clin Transplant 20: 28–34, 2022 10.6002/ect.2021.0183 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Lee JH, Muthukumar T, Kim J, Aull MJ, Watkins A, Kapur S, et al.: Antibiotic prophylaxis for ureteral stent removal after kidney transplantation. Clin Transplant 33: e13491, 2019 10.1111/ctr.13491 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    Chueng T, Suarez JF, Camargo JF: Efficacy and tolerability of fosfomycin in prevention of recurrent urinary tract infections among kidney transplant recipients. Transpl Infect Dis 21: e13042, 2019 10.1111/tid.13042 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    Arreola-Guerra JM, Rosado-Canto R, Alberú J, Maravilla E, Torres-González P, Criollo E, et al.: Fosfomycin trometamol in the prophylaxis of post-kidney transplant urinary tract infection: A controlled, randomized clinical trial. Transpl Infect Dis 20: e12980, 2018 10.1111/tid.12980 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Rosado-Canto R, Parra-Avila I, Tejeda-Maldonado J, Kauffman-Ortega C, Rodriguez-Covarrubias FT, Trujeque-Matos M, et al.: Perioperative fosfomycin disodium prophylaxis against urinary tract infection in renal transplant recipients: a randomized clinical trial. Nephrol Dial Transplant 35: 1996–2003, 2020 10.1093/ndt/gfz261 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Magruder M, Edusei E, Zhang L, Albakry S, Satlin MJ, Westblade LF, et al.: Gut commensal microbiota and decreased risk for Enterobacteriaceae bacteriuria and urinary tract infection. Gut Microbes 12: 1805281, 2020 10.1080/19490976.2020.1805281 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    Zgoura P, Waldecker C, Bauer F, Seibert FS, Rohn B, Schenker P, et al.: Vaccination against urinary tract infection after renal transplantation. Transplant Proc 52: 3192–3196, 2020 10.1016/j.transproceed.2020.06.018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21

    Tractenberg RE, Groah SL, Frost JK, Rounds AK, Davis E, Ljungberg IH, et al.: Effects of intravesical Lactobacillus Rhamnosus GG on urinary symptom burden in people with neurogenic lower urinary tract dysfunction. PM R 13: 695–706, 2021 10.1002/pmrj.12470 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Imlay H, Baum P, Brennan DC, Hanson KE, Hodges MR, Hodowanec AC, et al.; BK Disease Definitions Working Group of the Transplantation Associated Virus Infection Forum with the Forum for Collaborative Research: Consensus definitions of BK polyomavirus nephropathy in renal transplant recipients for clinical trials [published online ahead of print February 1, 2022]. Clin Infect Dis 10.1093/cid/ciac072 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    Chong S, Antoni M, Macdonald A, Reeves M, Harber M, Magee CN: BK virus: Current understanding of pathogenicity and clinical disease in transplantation. Rev Med Virol 29: e2044, 2019 10.1002/rmv.2044

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 24

    Molnar MZ, Potluri VS, Schaubel DE, Sise ME, Concepcion BP, Forbes RC, et al.: Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation. Am J Transplant 22: 599–609, 2022 10.1111/ajt.16834 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Velay A, Solis M, Benotmane I, Gantner P, Soulier E, Moulin B, et al.: Intravenous immunoglobulin administration significantly increases BKPyV genotype-specific neutralizing antibody titers in kidney transplant recipients. Antimicrob Agents Chemother 63: e00393-19, 2019 10.1128/AAC.00393-19 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 26

    Kaur A, Wilhelm M, Wilk S, Hirsch HH: BK polyomavirus-specific antibody and T-cell responses in kidney transplantation: update. Curr Opin Infect Dis 32: 575–583, 2019 10.1097/QCO.0000000000000602 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    Benotmane I, Solis M, Velay A, Cognard N, Olagne J, Gautier Vargas G, et al.: Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients-Results from a proof-of-concept study. Am J Transplant 21: 329–337, 2021 10.1111/ajt.16233 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28

    Adekunle RO, Mehta AK, Wang Z, Patzer RE, Zhang R: Early steps to kidney transplantation among persons with HIV and end-stage renal disease in ESRD network 6. Transpl Infect Dis 24: e13767, 2022 10.1111/tid.13767 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    Sawinski D: Kidney transplantation in patients with HIV. Kidney360 1: 705–711, 2020 10.34067/KID.0002112020 PubMed

  • 30

    Zheng X, Gong L, Xue W, Zeng S, Xu Y, Zhang Y, et al.: Kidney transplant outcomes in HIV-positive patients: a systematic review and meta-analysis. AIDS Res Ther 16: 37, 2019 10.1186/s12981-019-0253-z PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31

    Malat GE, Boyle SM, Jindal RM, Guy S, Xiao G, Harhay MN, et al.: Kidney transplantation in HIV-positive patients: A single-center, 16-year experience. Am J Kidney Dis 73: 112–118, 2019 10.1053/j.ajkd.2018.02.352 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Al-Adra D, Al-Qaoud T, Fowler K, Wong G: De novo malignancies after kidney transplantation. Clin J Am Soc Nephrol 17: 434–443, 2022 10.2215/CJN.14570920

  • 33

    Cheung CY, Tang SCW: An update on cancer after kidney transplantation. Nephrol Dial Transplant 34: 914–920, 2019 10.1093/ndt/gfy262 PubMed

  • 34

    Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS, et al.; American Society of Transplantation: Recommendations for the outpatient surveillance of renal transplant recipients. J Am Soc Nephrol 11: S1–S86, 2000 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Thet Z, Lam AK, Ranganathan D, Aung SY, Han T, Khoo TK: Reducing non-melanoma skin cancer risk in renal transplant recipients. Nephrology (Carlton) 26: 907–919, 2021 10.1111/nep.13939 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Coghill AE, Johnson LG, Berg D, Resler AJ, Leca N, Madeleine MM: Immunosuppressive medications and squamous cell skin carcinoma: Nested case-control study within the Skin Cancer after Organ Transplant (SCOT) Cohort. Am J Transplant 16: 565–573, 2016 10.1111/ajt.13596 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 37

    Chen AC, Martin AJ, Choy B, Fernández-Peñas P, Dalziell RA, McKenzie CA, et al.: A Phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med 373: 1618–1626, 2015 10.1056/NEJMoa1506197 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38

    Drago F, Ciccarese G, Cogorno L, Calvi C, Marsano LA, Parodi A: Prevention of non-melanoma skin cancers with nicotinamide in transplant recipients: a case-control study. Eur J Dermatol 27: 382–385, 2017 10.1684/ejd.2017.3025 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39

    Hadeler EK, Maderal AD: Drug interactions of natural supplements in dermatology: A review. Int J Dermatol 60: 1183–1189, 2021 10.1111/ijd.15389

  • 40

    Ma MKM, Lim WH, Turner RM, Chapman JR, Craig JC, Wong G: The risk of cancer in recipients of living-donor, standard and expanded criteria deceased donor kidney transplants: A registry analysis. Transplantation 98: 1286–1293, 2014 10.1097/TP.0000000000000375 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41

    Sprangers B, Riella LV, Dierickx D: Posttransplant lymphoproliferative disorder following kidney transplantation: A review. Am J Kidney Dis 78: 272–281, 2021 10.1053/j.ajkd.2021.01.015 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42

    Caillard S, Cellot E, Dantal J, Thaunat O, Provot F, Janbon B, et al.; French PTLD Registry: A French cohort study of kidney retransplantation after post-transplant lymphoproliferative disorders. Clin J Am Soc Nephrol 12: 1663–1670, 2017 10.2215/CJN.03790417 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43

    Rouphael B, Lankireddy S, Lazaryan A, Kukla A, Ibrahim HN, Matas AJ, et al.: Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder. Clin Transplant 30: 60–65, 2016 10.1111/ctr.12659 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 44

    Leeaphorn N, Thongprayoon C, Chewcharat A, Hansrivijit P, Jadlowiec CC, Cummings LS, et al.: Outcomes of kidney retransplantation in recipients with prior posttransplant lymphoproliferative disorders: An analysis of the 2000-2019 UNOS/OPTN database. Am J Transplant 21: 846–853, 2021 10.1111/ajt.16385 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 45

    Abdel-Wahab N, Safa H, Abudayyeh A, Johnson DH, Trinh VA, Zobniw CM, et al.: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature. J Immunother Cancer 7: 106, 2019 10.1186/s40425-019-0585-1 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46

    Rossi E, Schinzari G, Maiorano BA, Esposito I, Acampora A, Romagnoli J, et al.: Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: a systematic review. Immunotherapy 14: 65–75, 2022 10.2217/imt-2021-0195 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 47

    Ong SC, Mannon RB: Use of checkpoint inhibitors in a kidney transplant recipient with metastatic cancer. Clin J Am Soc Nephrol 15: 1190–1192, 2020 10.2215/CJN.15941219 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48

    Adam BA, Murakami N, Reid G, Du K, Jasim R, Boils CL, et al.: Gene expression profiling in kidney transplants with immune checkpoint inhibitor-associated adverse events. Clin J Am Soc Nephrol 16: 1376–1386, 2021 10.2215/CJN.00920121 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 49

    Khairallah P, Nickolas TL: Bone and mineral disease in kidney transplant recipients. Clin J Am Soc Nephrol 17: 121–130, 2022 10.2215/CJN.03410321 PubMed

  • 50

    Mathur A, Sutton W, Ahn JB, Prescott JD, Zeiger MA, Segev DL, et al.: Association between treatment of secondary hyperparathyroidism and posttransplant outcomes. Transplantation 105: e366–e374, 2021 10.1097/TP.0000000000003653 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 51

    Sutton W, Chen X, Patel P, Karzai S, Prescott JD, Segev DL, et al.: Prevalence and risk factors for tertiary hyperparathyroidism in kidney transplant recipients. Surgery 171: 69–76, 2022 10.1016/j.surg.2021.03.067 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 52

    Cruzado JM, Moreno P, Torregrosa JV, Taco O, Mast R, Gómez-Vaquero C, et al.: A randomized study comparing parathyroidectomy with cinacalcet for treating hypercalcemia in kidney allograft recipients with hyperparathyroidism. J Am Soc Nephrol 27: 2487–2494, 2016 10.1681/ASN.2015060622 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53

    Moreno P, Coloma A, Torregrosa JV, Montero N, Francos J, Codina S, et al.: Long-term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism. Clin Transplant 34: e13988, 2020 10.1111/ctr.13988 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 54

    Brazier F, Jouffroy J, Martinez F, Nguyen-Khoa T, Anglicheau D, Legendre C, et al.: Association of blood bicarbonate and pH with mineral metabolism disturbance and outcome after kidney transplantation. Am J Transplant 20: 1063–1075, 2020 10.1111/ajt.15686 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 55

    Gojowy D, Skiba K, Bartmanska M, Kolonko A, Wiecek A, Adamczak M: Is metabolic acidosis a novel risk factor for a long-term graft survival in patients after kidney transplantation? Kidney Blood Press Res 45: 702–712, 2020 10.1159/000508476 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 56

    Wiegand A, Ritter A, Graf N, Arampatzis S, Sidler D, Hadaya K, et al.: Preservation of kidney function in kidney transplant recipients by alkali therapy (Preserve-Transplant Study): Rationale and study protocol. BMC Nephrol 19: 177, 2018 10.1186/s12882-018-0956-8 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 57

    McMahon EJ, Campbell KL, Bauer JD, Mudge DW, Kelly JT: Altered dietary salt intake for people with chronic kidney disease. Cochrane Database Syst Rev 6: CD010070, 2021 10.1002/14651858.CD010070.pub3 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 58

    Wagner S, Merkling T, Metzger M, Bankir L, Laville M, Frimat L, et al.; CKD-REIN study group: Water intake and progression of chronic kidney disease: The CKD-REIN cohort study. Nephrol Dial Transplant 37: 730–739, 2022 10.1093/ndt/gfab036 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 59

    Ibrahim HN, Murad DN, Knoll GA: Thinking outside the box: Novel kidney protective strategies in kidney transplantation. Clin J Am Soc Nephrol 16: 1890–1897, 2021 10.2215/CJN.15070920 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 60

    Rangaswami J, Mathew RO, Parasuraman R, Tantisattamo E, Lubetzky M, Rao S, et al.: Cardiovascular disease in the kidney transplant recipient: epidemiology, diagnosis and management strategies. Nephrol Dial Transplant 34: 760–773, 2019 10.1093/ndt/gfz053 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 61

    Zoccali C, Roumeliotis S, Mallamaci F: Sleep apnea as a cardiorenal risk factor in CKD and renal transplant patients. Blood Purif 50: 642–648, 2021 10.1159/000513424 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 62

    Mallamaci F, Tripepi R, D’Arrigo G, Panuccio V, Parlongo G, Caridi G, et al.: Sleep-disordered breathing and 24-hour ambulatory blood pressure monitoring in renal transplant patients: Longitudinal study. J Am Heart Assoc 9: e016237, 2020 10.1161/JAHA.120.016237 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 63

    Bangalore S, Maron DJ, O’Brien SM, Fleg JL, Kretov EI, Briguori C, et al.; ISCHEMIA-CKD Research Group: Management of coronary disease in patients with advanced kidney disease. N Engl J Med 382: 1608–1618, 2020 10.1056/NEJMoa1915925 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 64

    Herzog CA, Simegn MA, Xu Y, Costa SP, Mathew RO, El-Hajjar MC, et al.: Kidney transplant list status and outcomes in the ISCHEMIA-CKD Trial. J Am Coll Cardiol 78: 348–361, 2021 10.1016/j.jacc.2021.05.001 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 65

    Nimmo A, Forsyth JL, Oniscu GC, Robb M, Watson C, Fotheringham J, et al.: A propensity score-matched analysis indicates screening for asymptomatic coronary artery disease does not predict cardiac events in kidney transplant recipients. Kidney Int 99: 431–442, 2021 10.1016/j.kint.2020.10.019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 66

    Ying T, Tran A, Webster AC, Klarenbach SW, Gill J, Chadban S, et al.: Screening for asymptomatic coronary artery disease in waitlisted kidney transplant candidates: A cost-utility analysis. Am J Kidney Dis 75: 693–704, 2020 10.1053/j.ajkd.2019.10.001 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 67

    Ying T, Gill J, Webster A, Kim SJ, Morton R, Klarenbach SW, et al.: Canadian-Australasian randomised trial of screening kidney transplant candidates for coronary artery disease-A trial protocol for the CARSK study. Am Heart J 214: 175–183, 2019 10.1016/j.ahj.2019.05.008 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 68

    Siddiqui MU, Junarta J, Marhefka GD: Coronary revascularization versus optimal medical therapy in renal transplant candidates with coronary artery disease: A systematic review and meta-analysis. J Am Heart Assoc 11: e023548, 2022 10.1161/JAHA.121.023548 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 69

    Chadban SJ, Ahn C, Axelrod DA, Foster BJ, Kasiske BL, Kher V, et al.: KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Transplantation 104: S11–S103, 2020 10.1097/TP.0000000000003136. Available at: https://kdigo.org/wp-content/uploads/2018/08/KDIGO-Txp-Candidate-GL-FINAL.pdf. Accessed February 28, 2022

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 70

    Whelan AM, Ku E: Use of ambulatory blood pressure monitoring in kidney transplant recipients. Nephrol Dial Transplant 34: 1437–1439, 2019 10.1093/ndt/gfz010 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 71

    Mallamaci F, Tripepi R, D’Arrigo G, Porto G, Versace MC, Marino C, et al.: Long-term blood pressure monitoring by office and 24-h ambulatory blood pressure in renal transplant patients: a longitudinal study. Nephrol Dial Transplant 34: 1558–1564, 2019 10.1093/ndt/gfy355 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 72

    Korogiannou M, Sarafidis P, Theodorakopoulou MP, Alexandrou ME, Xagas E, Boletis IN, et al.: Diagnostic performance of office versus ambulatory blood pressure in kidney transplant recipients. Am J Nephrol 52: 548–558, 2021 10.1159/000517358 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 73

    Korogiannou M, Sarafidis P, Theodorakopoulou MP, Alexandrou ME, Xagas E, Argyris A, et al.: Sex differences in ambulatory blood pressure levels, control, and phenotypes of hypertension in kidney transplant recipients. J Hypertens 40: 356–363, 2022 10.1097/HJH.0000000000003019 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 74

    Wadei HM, Amer H, Taler SJ, Cosio FG, Griffin MD, Grande JP, et al.: Diurnal blood pressure changes one year after kidney transplantation: Relationship to allograft function, histology, and resistive index. J Am Soc Nephrol 18: 1607–1615, 2007 10.1681/ASN.2006111289 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 75

    Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, et al.: Executive summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int 99: 559–569, 2021 10.1016/j.kint.2020.10.026 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 76

    Cross NB, Webster AC, Masson P, O’connell PJ, Craig JC: Antihypertensives for kidney transplant recipients: Systematic review and meta-analysis of randomized controlled trials. Transplantation 88: 7–18, 2009 10.1097/TP.0b013e3181a9e960 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 77

    Knoll GA, Fergusson D, Chassé M, Hebert P, Wells G, Tibbles LA, et al.: Ramipril versus placebo in kidney transplant patients with proteinuria: A multicentre, double-blind, randomised controlled trial. Lancet Diabetes Endocrinol 4: 318–326, 2016 10.1016/S2213-8587(15)00368-X PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 78

    Ibrahim HN, Jackson S, Connaire J, Matas A, Ney A, Najafian B, et al.: Angiotensin II blockade in kidney transplant recipients. J Am Soc Nephrol 24: 320–327, 2013 10.1681/ASN.2012080777 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 79

    Philipp T, Martinez F, Geiger H, Moulin B, Mourad G, Schmieder R, et al.: Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. Nephrol Dial Transplant 25: 967–976, 2010 10.1093/ndt/gfp581 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 80

    Hiremath S, Fergusson DA, Fergusson N, Bennett A, Knoll GA: Renin-angiotensin system blockade and long-term clinical outcomes in kidney transplant recipients: A meta-analysis of randomized controlled trials. Am J Kidney Dis 69: 78–86, 2017 10.1053/j.ajkd.2016.08.018 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 81

    Issa N, Ortiz F, Reule SA, Kukla A, Kasiske BL, Mauer M, et al.: The renin-aldosterone axis in kidney transplant recipients and its association with allograft function and structure [published correction appears in Kidney Int 87: 243, 2015]. Kidney Int 85: 404–415, 2014 10.1038/ki.2013.278 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 82

    Birdwell KA, Park M: Post-transplant cardiovascular disease. Clin J Am Soc Nephrol 16: 1878–1889, 2021 10.2215/CJN.00520121 PubMed

  • 83

    Holdaas H, Fellström B, Jardine AG, Holme I, Nyberg G, Fauchald P, et al.; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators: Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial. Lancet 361: 2024–2031, 2003 10.1016/S0140-6736(03)13638-0 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 84

    Holdaas H, Fellström B, Cole E, Nyberg G, Olsson AG, Pedersen TR, et al.; Assessment of LEscol in Renal Transplantation (ALERT) Study Investigators: Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: The ALERT extension study. Am J Transplant 5: 2929–2936, 2005 10.1111/j.1600-6143.2005.01105.x PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 85

    de Zeeuw D, Anzalone DA, Cain VA, Cressman MD, Heerspink HJ, Molitoris BA, et al.: Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): A randomised clinical trial. Lancet Diabetes Endocrinol 3: 181–190, 2015 10.1016/S2213-8587(14)70246-3 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 86

    Papasotiriou M, Ntrinias T, Savvidaki E, Papachristou E, Goumenos DS: Treatment of mixed dyslipidemia with alirocumab in a kidney transplant recipient: A case report. Transplant Proc 53: 2775–2778, 2021 10.1016/j.transproceed.2021.08.027 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 87

    Chowdhury TA: Post-transplant diabetes mellitus. Clin Med (Lond) 19: 392–395, 2019 10.7861/clinmed.2019-0195 PubMed

  • 88

    Li J, Chong A, Carey S: Dietary interventions on the prevention and management of diabetes in post-kidney transplantation - A systematic review. Nephrology (Carlton) 27: 269–280, 2022 10.1111/nep.13982 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 89

    Wissing KM, Abramowicz D, Weekers L, Budde K, Rath T, Witzke O, et al.: Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation. Am J Transplant 18: 1726–1734, 2018 10.1111/ajt.14665 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 90

    Axelrod DA, Cheungpasitporn W, Bunnapradist S, Schnitzler MA, Xiao H, McAdams-DeMarco M, et al.: Posttransplant diabetes mellitus and immunosuppression selection in older and obese kidney recipients. Kidney Med 4: 100377, 2021 10.1016/j.xkme.2021.08.012 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 91

    Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al.; DAPA-CKD Trial Committees and Investigators: Dapagliflozin in patients with chronic kidney disease. N Engl J Med 383: 1436–1446, 2020 10.1056/NEJMoa2024816 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 92

    Kanbay M, Demiray A, Afsar B, Karakus KE, Ortiz A, Hornum M, et al.: Sodium-glucose cotransporter 2 inhibitors for diabetes mellitus control after kidney transplantation: Review of the current evidence. Nephrology (Carlton) 26: 1007–1017, 2021 10.1111/nep.13941 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 93

    AlKindi F, Al-Omary HL, Hussain Q, Al Hakim M, Chaaban A, Boobes Y: Outcomes of SGLT2 inhibitors use in diabetic renal transplant patients. Transplant Proc 52: 175–178, 2020 10.1016/j.transproceed.2019.11.007 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 94

    Halden TAS, Kvitne KE, Midtvedt K, Rajakumar L, Robertsen I, Brox J, et al.: Efficacy and safety of empagliflozin in renal transplant recipients with posttransplant diabetes mellitus. Diabetes Care 42: 1067–1074, 2019 10.2337/dc19-0093 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 95

    Shuster S, Al-Hadhrami Z, Moore S, Awad S, Shamseddin MK: Use of sodium-glucose cotransporter-2 inhibitors in renal transplant patients with diabetes: A brief review of the current literature. Can J Diabetes 46: 207–212, 2022 10.1016/j.jcjd.2021.06.003 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 96

    Ertuglu LA, Porrini E, Hornum M, Demiray A, Afsar B, Ortiz A, et al.: Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation. Transpl Int 34: 1341–1359, 2021 10.1111/tri.13883 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 97

    Hart A, Lentine KL, Smith JM, Miller JM, Skeans MA, Prentice M, et al.: OPTN/SRTR 2019 Annual Data Report: Kidney. Am J Transplant 21: 21–137, 2021 10.1111/ajt.16502 PubMed. Available at: https://srtr.transplant.hrsa.gov/annual_reports/2019_ADR_Preview.aspx. Accessed January 25, 2022

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 98

    Veroux M, Mattone E, Cavallo M, Gioco R, Corona D, Volpicelli A, et al.: Obesity and bariatric surgery in kidney transplantation: A clinical review. World J Diabetes 12: 1563–1575, 2021 10.4239/wjd.v12.i9.1563 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 99

    Sureshkumar KK, Chopra B, Josephson MA, Shah PB, McGill RL: Recipient obesity and kidney transplant outcomes: A mate-kidney analysis. Am J Kidney Dis 78: 501–510.e1, 2021 10.1053/j.ajkd.2021.02.332 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 100

    Cohen JB, Lim MA, Tewksbury CM, Torres-Landa S, Trofe-Clark J, Abt PL, et al.: Bariatric surgery before and after kidney transplantation: Long-term weight loss and allograft outcomes. Surg Obes Relat Dis 15: 935–941, 2019 10.1016/j.soard.2019.04.002 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 101

    Ku E, McCulloch CE, Roll GR, Posselt A, Grimes BA, Johansen KL: Bariatric surgery prior to transplantation and risk of early hospital re-admission, graft failure, or death following kidney transplantation. Am J Transplant 21: 3750–3757, 2021 10.1111/ajt.16779 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 102

    Spaggiari M, Di Cocco P, Tulla K, Kaylan KB, Masrur MA, Hassan C, et al.: Simultaneous robotic kidney transplantation and bariatric surgery for morbidly obese patients with end-stage renal failure. Am J Transplant 21: 1525–1534, 2021 10.1111/ajt.16322 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 103

    Anis KH, Weinrauch LA, D’Elia JA: Effects of smoking on solid organ transplantation outcomes. Am J Med 132: 413–419, 2019 10.1016/j.amjmed.2018.11.005 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 104

    Formanek P, Salisbury-Afshar E, Afshar M: Helping patients with ESRD and earlier stages of CKD to quit smoking. Am J Kidney Dis 72: 255–266, 2018 10.1053/j.ajkd.2018.01.057 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 105

    Devresse A, Gohy S, Robert A, Kanaan N: How to manage cigarette smoking in kidney transplant candidates and recipients? Clin Kidney J 14: 2295–2303, 2021 10.1093/ckj/sfab072 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 106

    Walther CP, Nambi V, Hanania NA, Navaneethan SD: Diagnosis and management of pulmonary hypertension in patients with CKD. Am J Kidney Dis 75: 935–945, 2020 10.1053/j.ajkd.2019.12.005 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 107

    Lentine KL, Lam NN, Caliskan Y, Xiao H, Axelrod DA, Costa SP, et al.: Incidence, clinical correlates, and outcomes of pulmonary hypertension after kidney transplantation: Analysis of linked US registry and Medicare billing claims. Transplantation 106: 666–675, 2022 10.1097/TP.0000000000003783 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 108

    Rao NN, Stokes MB, Rajwani A, Ullah S, Williams K, King D, et al.: Effects of arteriovenous fistula ligation on cardiac structure and function in kidney transplant recipients. Circulation 139: 2809–2818, 2019 10.1161/CIRCULATIONAHA.118.038505 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 109

    Lubetzky M, Tantisattamo E, Molnar MZ, Lentine KL, Basu A, Parsons RF, et al.: The failing kidney allograft: A review and recommendations for the care and management of a complex group of patients. Am J Transplant 21: 2937–2949, 2021 10.1111/ajt.16717 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 110

    Uffing A, Hullekes F, Riella LV, Hogan JJ: Recurrent glomerular disease after kidney transplantation. Clin J Am Soc Nephrol 16: 1730–1742, 2021 10.2215/CJN.00280121 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 111

    Mannon RB: Acute kidney injury in kidney transplants: New insights. Nephron 143: 193–196, 2019 10.1159/000500550 PubMed

  • 112

    Bahl D, Haddad Z, Datoo A, Qazi YA: Delayed graft function in kidney transplantation. Curr Opin Organ Transplant 24: 82–86, 2019 10.1097/MOT.0000000000000604 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 113

    Metter C, Torrealba JR: Pathology of the kidney allograft. Semin Diagn Pathol 37: 148–153, 2020 10.1053/j.semdp.2020.03.005 PubMed

  • 114

    Tantisattamo E, Hanna RM, Reddy UG, Ichii H, Dafoe DC, Danovitch GM, et al.: Novel options for failing allograft in kidney transplanted patients to avoid or defer dialysis therapy. Curr Opin Nephrol Hypertens 29: 80–91, 2020 10.1097/MNH.0000000000000572 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 115

    Davis S, Mohan S: Managing patients with failing kidney allograft: Many questions remain. Clin J Am Soc Nephrol 17: 444–451, 2022 10.2215/CJN.14620920 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 116

    Huml AM, Sehgal AR: Hemodialysis quality metrics in the first year following a failed kidney transplant. Am J Nephrol 50: 161–167, 2019 10.1159/000501605 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 117

    Agrawal N, Pavlakis M: Caring for the patient with a failing allograft: Challenges and opportunities. Curr Opin Organ Transplant 24: 416–423, 2019 10.1097/MOT.0000000000000655 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 118

    Arshad A, Jackson-Spence F, Sharif A: Development and evaluation of dedicated low clearance transplant clinics for patients with failing kidney transplants. J Ren Care 45: 51–58, 2019 10.1111/jorc.12268 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 119

    United States Renal Data System: 2021 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States. Available at: https://adr.usrds.org/202 1. Accessed March 2, 2022

    • PubMed
    • Export Citation
  • 120

    Schold JD, Augustine JJ, Huml AM, O’Toole J, Sedor JR, Poggio ED: Modest rates and wide variation in timely access to repeat kidney transplantation in the United States. Am J Transplant 20: 769–778, 2020 10.1111/ajt.15646 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 121

    Kainz A, Kammer M, Reindl-Schwaighofer R, Strohmaier S, Petr V, Viklicky O, et al.: Waiting time for second kidney transplantation and mortality. Clin J Am Soc Nephrol 17: 90–97, 2022 10.2215/CJN.07620621 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 122

    Alhamad T, Lubetzky M, Lentine KL, Edusei E, Parsons R, Pavlakis M, et al.: Kidney recipients with allograft failure, transition of kidney care (KRAFT): A survey of contemporary practices of transplant providers. Am J Transplant 21: 3034–3042, 2021 10.1111/ajt.16523 PubMed

    • PubMed
    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 353 176 6
Full Text Views 659 383 26
PDF Downloads 861 478 28